Association of Gout with Rheumatoid Arthritis and Pulmonary Toxicity of Methotrexate: A Case Report about Algerian Women

Authors

  • Siheme Ouali Department of Biology, Djillali Liabes University of Sidi bel Abbes, Laboratory of Molecular Microbiology, Proteomics and Health, Algeria
  • Khalida ZEMRI Department of Biology, Djillali Liabes University of Sidi bel Abbes, Laboratory of Molecular Microbiology, Proteomics and Health, Algeria
  • Khedoudja KANOUN Department of Biology, Djillali Liabes University of Sidi bel Abbes, Laboratory of Molecular Microbiology, Proteomics and Health, Algeria
  • Noria HARIR Department of Biology, Djillali Liabes University of Sidi bel Abbes, Laboratory of Molecular Microbiology, Proteomics and Health, Algeria
  • Zahira BENAISSA Department of Biology, Djillali Liabes University of Sidi bel Abbes, Laboratory of Molecular Microbiology, Proteomics and Health, Algeria
  • Feriel SELLAM National Research Center of Biotechnology. CRBT
  • Karima KAROUBI Department of internal medicine, EPH Benisaf- AinTemouchent, Algeria
  • Sid Tadj HEBRI Department of internal medicine, CHU Sidi BelAbbes,Algeria

Abstract

Coexistence of rheumatoid arthritis and gout is considered as rare  however some patients may gather both diseases. Long-term treatment with Methotrexate may cause pulmonary pathology. We report a case  of a 48-year-old Algerian  woman with medical history (swelling of knee  and  joint pain in the shoulders and hands)  diagnosed with  Rheumatoid  Arthritis  (RA), after  3 years of  self-medication with Methotrexate;  she returned with hyperurecimia that   confirmed the co-presence of the gout and RA as well as a pneumonia confirmed with clinical  sign and chest X-Ray. Methotrexate dose compliance can reduce adverse effects.

Keywords: Rheumatoid arthritis; Gout; Pneumonia; Methotrexate; Toxicity.

Keywords:

Rheumatoid arthritis, Gout, Pneumonia, Methotrexate, Toxicity

DOI

https://doi.org/10.22270/jddt.v10i4.4262

References

Andia A, Alassane S, Brah S, Daou M, Hamadou A , Adehossi E , Cheour E Rheumatoid Arthritis at The National Hospital of Niamey: A 42 cases report. Revue africaine de médecine interne (RAFMI), 2016; 3(2):29-32.

Shi Y, Mucsi AD, Ng G. Monosodium urate crystals in inflammation and immunity. Immunol Rev, 2010; 233:203-17.

Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature, 2006; 440:237-41.

Kuo CF, Tsai WP, Liou LB. Rare copresent rheumatoid arthritis and gout: comparison with pure rheumatoid arthritis and a literature review. Clin Rheumatol, 2008; 27:231–5.

Jebakumar AJ, Udayakumar PD, Crowson CS, et al. Occurrenceof gout in rheumatoid arthritis: it does happen! A population-based study. Int J Clin Rheum, 2013; 8:433–7.

Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008. Arthritis Rheum, 2011; 63(10):3136–3141.

Gubner R, August S, Ginsberg V. Therapeutic suppression of tissue reactivity. II. Effect of aminopterin in rheumatoid arthritis and psoriasis. Am J Med Sci, 1951; 221:176-182.

Clarysee AM, Cathey WJ, Cartwright GE, et al. Pulmonary disease complicating intermittent therapy with methotrexate. JAMA, 1969; 209:1861e1864.

SOSTMAN HD, MATTHAY RA, PUTMAN CE. Cytotoxic drug induced lung disease. Am. J. Med, 1977; 62:608-615.

DAY RO, QUINN DI, BROOKS PM, CONAGHAN PG. Hazards of low dose methotrexate. Aust. NZ. J. Med, 1995; 25:670-674.

KREMER JM, ALARCON GS, WEINBLATT ME et al. Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis. A multicenter study with literature review. Arthritis Rheum, 1997; 40:1829-1837.

Yunt, Z. X., & Solomon, J. J. Lung Disease in Rheumatoid Arthritis. Rheumatic Disease Clinics of North America, 2015; 41(2):225–236.

Published

2020-07-15
Statistics
Abstract Display: 629
PDF Downloads: 690

How to Cite

1.
Ouali S, ZEMRI K, KANOUN K, HARIR N, BENAISSA Z, SELLAM F, et al. Association of Gout with Rheumatoid Arthritis and Pulmonary Toxicity of Methotrexate: A Case Report about Algerian Women. J. Drug Delivery Ther. [Internet]. 2020 Jul. 15 [cited 2026 Jan. 12];10(4):216-8. Available from: https://jddtonline.info/index.php/jddt/article/view/4262

Issue

Vol. 10 No. 4 (2020): Volume 10, Issue 4, July-August 2020

Section

Case Studies

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

How to Cite

1.
Ouali S, ZEMRI K, KANOUN K, HARIR N, BENAISSA Z, SELLAM F, et al. Association of Gout with Rheumatoid Arthritis and Pulmonary Toxicity of Methotrexate: A Case Report about Algerian Women. J. Drug Delivery Ther. [Internet]. 2020 Jul. 15 [cited 2026 Jan. 12];10(4):216-8. Available from: https://jddtonline.info/index.php/jddt/article/view/4262
Crossref
Scopus
Google Scholar
Europe PMC

Most read articles by the same author(s)